“…In particular, we reported those characteristics that are related to the highest performance reached by RF in each study. Regarding the cohort diagnosis, two works (Tripoliti et al, 2007 ; Lebedev et al, 2014 ) investigated Alzheimer's patients (AD) and healthy controls (HC), four works (Cabral et al, 2013 ; Sivapriya et al, 2015 ; Maggipinto et al, 2017 ; Son et al, 2017 ) had AD, HC, and MCI, two studies (Gray et al, 2013 ; Moradi et al, 2015 ) considered AD, HC, stable MCI (sMCI), and progressive MCI (pMCI, converted to AD), two had sMCI and pMCI (Wang et al, 2016 ; Ardekani et al, 2017 ), one had HC and MCI (Lebedeva et al, 2017 ) and one (Oppedal et al, 2015 ) had AD, HC, and Lewy-body dementia (LBD) patients.…”